CARDIAC PACING LEADS MARKET ANALYSIS

Regional Analysis

North America holds dominant position in the global cardiac pacing leads market, owing to the adoption of new technologies advancement. According to the United Nations, the number of people aged 60 years or above is expected to more than double by 2050 and to more than triple by 2100, increasing from 962 million globally in 2017 to 2.1 billion in 2050. 

North America is expected to gain significant rise in the global cardiac pacing leads market over the forecast period, owing to increasing lifestyle-related disorders, technological advancements, and increased investment on healthcare infrastructure. The key players operating in the cardiac pacing leads market are focused on innovating efficient cardiac lead devices, and further launching them in emerging markets to meet the demand of consumers of various types of cardiac pacing leads. For instance, on  April 9, 2019, Oscor, Inc. announced strategic alliance with Micro Interventional Devices Inc. to strengthen the capabilities to develop and commercialize new heart disease device.

Furthermore, Europe is the second largest growing market in global cardiac pacing leads market, owing to high incidence of cardiac disease. 

On the basis of product type, the global cardiac pacing leads market is segmented into:

• Unipolar
• Bipolar
• Others

On the basis of technology, the global cardiac pacing leads market is segmented into:

• Transcutaneous Pacing
• Trans Venous Pacing
• Epicardial Pacing

On the basis of end user, the global cardiac pacing leads market is segmented into:

• Catheterization Labs
• Orthopedic Clinic
• Hospitals
• Ambulatory Surgery Centers

On the basis of region, the global cardiac pacing leads market is segmented into:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa